XML 63 R50.htm IDEA: XBRL DOCUMENT v3.25.3
SUBSEQUENT EVENTS (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 44 Months Ended
Oct. 27, 2025
May 12, 2025
Mar. 21, 2024
Nov. 06, 2025
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2020
Subsequent Event [Line Items]                  
Consideration received on transaction   $ 21,100,000 $ 21,900,000            
Revenues         $ 581,000 $ 49,412,000 $ 25,324,000 $ 50,249,000  
Pfizer Inc. | Recognition of license revenue                  
Subsequent Event [Line Items]                  
Revenues         $ 0 $ 0 $ 5,000,000 $ 0 $ 134,000,000
Subsequent Event                  
Subsequent Event [Line Items]                  
Sale of stock, number of shares issued in transaction (in shares)       14,500,000          
Consideration received on transaction       $ 9,100,000          
Subsequent Event | Pfizer Inc. | Recognition of license revenue                  
Subsequent Event [Line Items]                  
Revenues $ 6,000,000